Cytovance Biologics Announces Dr. Axel Schleyer to Expand Footprint and Service Offering as Chief Commercial Officer ...Middle East

PR Newswire - News
Cytovance Biologics, a US-based, large molecule CDMO, announced the addition of industry veteran Axel Schleyer as Chief Commercial Officer to lead future expansion in microbial and mammalian services and CGMP manufacturing capacity. OKLAHOMA CITY, Sept. 27, 2023 /PRNewswire/ -- Cytovance...

Hence then, the article about cytovance biologics announces dr axel schleyer to expand footprint and service offering as chief commercial officer was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Cytovance Biologics Announces Dr. Axel Schleyer to Expand Footprint and Service Offering as Chief Commercial Officer )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News